Launch Therapeutics
USEntry
2022
Hold
4yr
Status
Active
Who owns Launch Therapeutics?
Launch Therapeutics is an American Biotech company, currently owned by Abingworth since 2022.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
More from Abingworth Clinical Co-Development Fund 2
Other portfolio companies in the same fund.
More Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Launch Therapeutics?
Launch Therapeutics is currently owned by Abingworth, through Abingworth Clinical Co-Development Fund 2, since 2022.
When did Abingworth acquire Launch Therapeutics?
Abingworth acquired Launch Therapeutics in 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue